Legal Developments
The justice system plays an essential role in the safety of prescription drugs and medical devices. When regulatory agencies fail to act, a courthouse becomes the only way to hold manufacturers accountable. At MedTruth, we believe the vitality of a nation relies on the justice upheld by its people. Keep your hand on the pulse of mass torts law and other litigation regarding patient harm and consumer safety.
Top Articles on Legal Developments
California Wildfires Spark Legal and Political Battles for PG&E
Nicole Knight · December 5, 2019
PG&E, the power provider implicated in the recent California wildfires, now faces legal action by the state.
Legal DevelopmentsIn 3 Months, 20,000 More Plaintiffs Claim Roundup Caused Cancer
Emma Schkloven · November 26, 2019
The number of plaintiffs claiming Roundup caused their cancer has more than doubled to 42,700 in the last three months.
Legal DevelopmentsSeven Plaintiffs Refile J&J Talc Lawsuit to Prosecute Claire's and Others
James Parker · August 1, 2019
Judge George H. Wu of California granted case dismissal to seven plaintiffs in a talc lawsuit against Johnson & Johnson for their failure to label talc products. The plaintiffs will refile - adding more cases to their complaint and holding other companies liable.
Legal Developments-
California Wildfires Spark Legal and Political Battles for PG&E
Nicole Knight · December 5, 2019
PG&E, the power provider implicated in the recent California wildfires, now faces legal action by the state.
Legal Developments -
In 3 Months, 20,000 More Plaintiffs Claim Roundup Caused Cancer
Emma Schkloven · November 26, 2019
The number of plaintiffs claiming Roundup caused their cancer has more than doubled to 42,700 in the last three months.
Legal Developments -
Seven Plaintiffs Refile J&J Talc Lawsuit to Prosecute Claire's and Others
James Parker · August 1, 2019
Judge George H. Wu of California granted case dismissal to seven plaintiffs in a talc lawsuit against Johnson & Johnson for their failure to label talc products. The plaintiffs will refile - adding more cases to their complaint and holding other companies liable.
Legal Developments
Hundreds of Cases Against Zofran Manufacturer Still Pending
Nicole Knight · March 13, 2020
More than 500 cases are pending against GlaxoSmithKline, claiming the drugmaker aggressively marketed Zofran to pregnant women without informing them of the potential risk of birth defects.
Legal DevelopmentsHundreds of Cases Against Zofran Manufacturer Still Pending
Nicole Knight · March 13, 2020
More than 500 cases are pending against GlaxoSmithKline, claiming the drugmaker aggressively marketed Zofran to pregnant women without informing them of the potential risk of birth defects.
Legal DevelopmentsHundreds of Cases Against Zofran Manufacturer Still Pending
Nicole Knight · March 13, 2020
More than 500 cases are pending against GlaxoSmithKline, claiming the drugmaker aggressively marketed Zofran to pregnant women without informing them of the potential risk of birth defects.
Legal DevelopmentsGet our reporting in your inbox
Hundreds of Cases Against Zofran Manufacturer Still Pending
Nicole Knight · March 13, 2020
More than 500 cases are pending against GlaxoSmithKline, claiming the drugmaker aggressively marketed Zofran to pregnant women without informing them of the potential risk of birth defects.
Legal DevelopmentsHundreds of Cases Against Zofran Manufacturer Still Pending
Nicole Knight · March 13, 2020
More than 500 cases are pending against GlaxoSmithKline, claiming the drugmaker aggressively marketed Zofran to pregnant women without informing them of the potential risk of birth defects.
Legal DevelopmentsHundreds of Cases Against Zofran Manufacturer Still Pending
Nicole Knight · March 13, 2020
More than 500 cases are pending against GlaxoSmithKline, claiming the drugmaker aggressively marketed Zofran to pregnant women without informing them of the potential risk of birth defects.
Legal DevelopmentsHundreds of Cases Against Zofran Manufacturer Still Pending
Nicole Knight · March 13, 2020
More than 500 cases are pending against GlaxoSmithKline, claiming the drugmaker aggressively marketed Zofran to pregnant women without informing them of the potential risk of birth defects.
Legal DevelopmentsHundreds of Cases Against Zofran Manufacturer Still Pending
Nicole Knight · March 13, 2020
More than 500 cases are pending against GlaxoSmithKline, claiming the drugmaker aggressively marketed Zofran to pregnant women without informing them of the potential risk of birth defects.
Legal DevelopmentsMore States Sue JUUL As FDA's Regulatory Deadline Approaches
Kimberly Nicoletti · March 11, 2020
As more states file suit against Juul, the vaping manufacturer prepares to submit an application to the FDA to prove that e-cigarettes benefit smokers more than they harm teenagers.
Legal DevelopmentsMore States Sue JUUL As FDA's Regulatory Deadline Approaches
Kimberly Nicoletti · March 11, 2020
As more states file suit against Juul, the vaping manufacturer prepares to submit an application to the FDA to prove that e-cigarettes benefit smokers more than they harm teenagers.
Legal DevelopmentsMore States Sue JUUL As FDA's Regulatory Deadline Approaches
Kimberly Nicoletti · March 11, 2020
As more states file suit against Juul, the vaping manufacturer prepares to submit an application to the FDA to prove that e-cigarettes benefit smokers more than they harm teenagers.
Legal DevelopmentsMore States Sue JUUL As FDA's Regulatory Deadline Approaches
Kimberly Nicoletti · March 11, 2020
As more states file suit against Juul, the vaping manufacturer prepares to submit an application to the FDA to prove that e-cigarettes benefit smokers more than they harm teenagers.
Legal DevelopmentsMore States Sue JUUL As FDA's Regulatory Deadline Approaches
Kimberly Nicoletti · March 11, 2020
As more states file suit against Juul, the vaping manufacturer prepares to submit an application to the FDA to prove that e-cigarettes benefit smokers more than they harm teenagers.
Legal DevelopmentsMore States Sue JUUL As FDA's Regulatory Deadline Approaches
Kimberly Nicoletti · March 11, 2020
As more states file suit against Juul, the vaping manufacturer prepares to submit an application to the FDA to prove that e-cigarettes benefit smokers more than they harm teenagers.
Legal DevelopmentsMore States Sue JUUL As FDA's Regulatory Deadline Approaches
Kimberly Nicoletti · March 11, 2020
As more states file suit against Juul, the vaping manufacturer prepares to submit an application to the FDA to prove that e-cigarettes benefit smokers more than they harm teenagers.
Legal DevelopmentsMore States Sue JUUL As FDA's Regulatory Deadline Approaches
Kimberly Nicoletti · March 11, 2020
As more states file suit against Juul, the vaping manufacturer prepares to submit an application to the FDA to prove that e-cigarettes benefit smokers more than they harm teenagers.
Legal DevelopmentsCorporations Accused of Allowing Excess NDMA in Zantac MDL
James Parker · March 4, 2020
A Zantac multidistrict litigation hearing was held to decide how to proceed with over 100 lawsuits filed alleging that the makers of Zantac and its counterparts concealed fatal defects in the drug’s ingredients.
Legal DevelopmentsCorporations Accused of Allowing Excess NDMA in Zantac MDL
James Parker · March 4, 2020
A Zantac multidistrict litigation hearing was held to decide how to proceed with over 100 lawsuits filed alleging that the makers of Zantac and its counterparts concealed fatal defects in the drug’s ingredients.
Legal DevelopmentsCorporations Accused of Allowing Excess NDMA in Zantac MDL
James Parker · March 4, 2020
A Zantac multidistrict litigation hearing was held to decide how to proceed with over 100 lawsuits filed alleging that the makers of Zantac and its counterparts concealed fatal defects in the drug’s ingredients.
Legal DevelopmentsCorporations Accused of Allowing Excess NDMA in Zantac MDL
James Parker · March 4, 2020
A Zantac multidistrict litigation hearing was held to decide how to proceed with over 100 lawsuits filed alleging that the makers of Zantac and its counterparts concealed fatal defects in the drug’s ingredients.
Legal DevelopmentsCorporations Accused of Allowing Excess NDMA in Zantac MDL
James Parker · March 4, 2020
A Zantac multidistrict litigation hearing was held to decide how to proceed with over 100 lawsuits filed alleging that the makers of Zantac and its counterparts concealed fatal defects in the drug’s ingredients.
Legal DevelopmentsCorporations Accused of Allowing Excess NDMA in Zantac MDL
James Parker · March 4, 2020
A Zantac multidistrict litigation hearing was held to decide how to proceed with over 100 lawsuits filed alleging that the makers of Zantac and its counterparts concealed fatal defects in the drug’s ingredients.
Legal DevelopmentsCorporations Accused of Allowing Excess NDMA in Zantac MDL
James Parker · March 4, 2020
A Zantac multidistrict litigation hearing was held to decide how to proceed with over 100 lawsuits filed alleging that the makers of Zantac and its counterparts concealed fatal defects in the drug’s ingredients.
Legal DevelopmentsCorporations Accused of Allowing Excess NDMA in Zantac MDL
James Parker · March 4, 2020
A Zantac multidistrict litigation hearing was held to decide how to proceed with over 100 lawsuits filed alleging that the makers of Zantac and its counterparts concealed fatal defects in the drug’s ingredients.
Legal DevelopmentsJ&J Fined More Than $180 Million for Asbestos Contamination
James Parker · February 6, 2020
A New Jersey jury imposed a now-reduced verdict of three-quarters of a million dollars in punitive fines to Johnson & Johnson.
Legal DevelopmentsNational Trial Lawyers Summit Hosts First-Ever Women's Leadership Forum
Andrea Sarcos · February 6, 2020
Nearly 50 trial lawyers gathered at the Women’s Leadership Forum, a dedicated development session in support of women in the profession, at the National Trial Lawyers Summit in Miami, Florida.
Legal DevelopmentsJ&J Fined More Than $180 Million for Asbestos Contamination
James Parker · February 6, 2020
A New Jersey jury imposed a now-reduced verdict of three-quarters of a million dollars in punitive fines to Johnson & Johnson.
Legal DevelopmentsJ&J Fined More Than $180 Million for Asbestos Contamination
James Parker · February 6, 2020
A New Jersey jury imposed a now-reduced verdict of three-quarters of a million dollars in punitive fines to Johnson & Johnson.
Legal DevelopmentsJ&J Fined More Than $180 Million for Asbestos Contamination
James Parker · February 6, 2020
A New Jersey jury imposed a now-reduced verdict of three-quarters of a million dollars in punitive fines to Johnson & Johnson.
Legal DevelopmentsNational Trial Lawyers Summit Hosts First-Ever Women's Leadership Forum
Andrea Sarcos · February 6, 2020
Nearly 50 trial lawyers gathered at the Women’s Leadership Forum, a dedicated development session in support of women in the profession, at the National Trial Lawyers Summit in Miami, Florida.
Legal DevelopmentsNational Trial Lawyers Summit Hosts First-Ever Women's Leadership Forum
Andrea Sarcos · February 6, 2020
Nearly 50 trial lawyers gathered at the Women’s Leadership Forum, a dedicated development session in support of women in the profession, at the National Trial Lawyers Summit in Miami, Florida.
Legal DevelopmentsNational Trial Lawyers Summit Hosts First-Ever Women's Leadership Forum
Andrea Sarcos · February 6, 2020
Nearly 50 trial lawyers gathered at the Women’s Leadership Forum, a dedicated development session in support of women in the profession, at the National Trial Lawyers Summit in Miami, Florida.
Legal DevelopmentsNational Trial Lawyers Summit Hosts First-Ever Women's Leadership Forum
Andrea Sarcos · February 6, 2020
Nearly 50 trial lawyers gathered at the Women’s Leadership Forum, a dedicated development session in support of women in the profession, at the National Trial Lawyers Summit in Miami, Florida.
Legal DevelopmentsJ&J Fined More Than $180 Million for Asbestos Contamination
James Parker · February 6, 2020
A New Jersey jury imposed a now-reduced verdict of three-quarters of a million dollars in punitive fines to Johnson & Johnson.
Legal DevelopmentsNational Trial Lawyers Summit Hosts First-Ever Women's Leadership Forum
Andrea Sarcos · February 6, 2020
Nearly 50 trial lawyers gathered at the Women’s Leadership Forum, a dedicated development session in support of women in the profession, at the National Trial Lawyers Summit in Miami, Florida.
Legal DevelopmentsJ&J Fined More Than $180 Million for Asbestos Contamination
James Parker · February 6, 2020
A New Jersey jury imposed a now-reduced verdict of three-quarters of a million dollars in punitive fines to Johnson & Johnson.
Legal DevelopmentsNational Trial Lawyers Summit Hosts First-Ever Women's Leadership Forum
Andrea Sarcos · February 6, 2020
Nearly 50 trial lawyers gathered at the Women’s Leadership Forum, a dedicated development session in support of women in the profession, at the National Trial Lawyers Summit in Miami, Florida.
Legal DevelopmentsNational Trial Lawyers Summit Hosts First-Ever Women's Leadership Forum
Andrea Sarcos · February 6, 2020
Nearly 50 trial lawyers gathered at the Women’s Leadership Forum, a dedicated development session in support of women in the profession, at the National Trial Lawyers Summit in Miami, Florida.
Legal DevelopmentsJ&J Fined More Than $180 Million for Asbestos Contamination
James Parker · February 6, 2020
A New Jersey jury imposed a now-reduced verdict of three-quarters of a million dollars in punitive fines to Johnson & Johnson.
Legal DevelopmentsJ&J Fined More Than $180 Million for Asbestos Contamination
James Parker · February 6, 2020
A New Jersey jury imposed a now-reduced verdict of three-quarters of a million dollars in punitive fines to Johnson & Johnson.
Legal DevelopmentsCalifornia Ethicon Mesh Judgement Results in $344 Million Fine for J&J
James Parker · January 30, 2020
Johnson & Johnson's subsidiary is set to pay $344 million for failing to inform consumers about the risks of transvaginal mesh.
Legal DevelopmentsCalifornia Ethicon Mesh Judgement Results in $344 Million Fine for J&J
James Parker · January 30, 2020
Johnson & Johnson's subsidiary is set to pay $344 million for failing to inform consumers about the risks of transvaginal mesh.
Legal DevelopmentsCalifornia Ethicon Mesh Judgement Results in $344 Million Fine for J&J
James Parker · January 30, 2020
Johnson & Johnson's subsidiary is set to pay $344 million for failing to inform consumers about the risks of transvaginal mesh.
Legal DevelopmentsCalifornia Ethicon Mesh Judgement Results in $344 Million Fine for J&J
James Parker · January 30, 2020
Johnson & Johnson's subsidiary is set to pay $344 million for failing to inform consumers about the risks of transvaginal mesh.
Legal DevelopmentsCalifornia Ethicon Mesh Judgement Results in $344 Million Fine for J&J
James Parker · January 30, 2020
Johnson & Johnson's subsidiary is set to pay $344 million for failing to inform consumers about the risks of transvaginal mesh.
Legal DevelopmentsCalifornia Ethicon Mesh Judgement Results in $344 Million Fine for J&J
James Parker · January 30, 2020
Johnson & Johnson's subsidiary is set to pay $344 million for failing to inform consumers about the risks of transvaginal mesh.
Legal DevelopmentsCalifornia Ethicon Mesh Judgement Results in $344 Million Fine for J&J
James Parker · January 30, 2020
Johnson & Johnson's subsidiary is set to pay $344 million for failing to inform consumers about the risks of transvaginal mesh.
Legal DevelopmentsCalifornia Ethicon Mesh Judgement Results in $344 Million Fine for J&J
James Parker · January 30, 2020
Johnson & Johnson's subsidiary is set to pay $344 million for failing to inform consumers about the risks of transvaginal mesh.
Legal DevelopmentsBoynton Beach Zantac Lawsuit Filed by Local Woman
James Parker · January 15, 2020
A Florida woman has filed a lawsuit alleging that Zantac manufacturers deliberately allowed an unsafe product to remain on the market.
Legal DevelopmentsBoynton Beach Zantac Lawsuit Filed by Local Woman
James Parker · January 15, 2020
A Florida woman has filed a lawsuit alleging that Zantac manufacturers deliberately allowed an unsafe product to remain on the market.
Legal DevelopmentsBoynton Beach Zantac Lawsuit Filed by Local Woman
James Parker · January 15, 2020
A Florida woman has filed a lawsuit alleging that Zantac manufacturers deliberately allowed an unsafe product to remain on the market.
Legal DevelopmentsBoynton Beach Zantac Lawsuit Filed by Local Woman
James Parker · January 15, 2020
A Florida woman has filed a lawsuit alleging that Zantac manufacturers deliberately allowed an unsafe product to remain on the market.
Legal DevelopmentsBoynton Beach Zantac Lawsuit Filed by Local Woman
James Parker · January 15, 2020
A Florida woman has filed a lawsuit alleging that Zantac manufacturers deliberately allowed an unsafe product to remain on the market.
Legal DevelopmentsBoynton Beach Zantac Lawsuit Filed by Local Woman
James Parker · January 15, 2020
A Florida woman has filed a lawsuit alleging that Zantac manufacturers deliberately allowed an unsafe product to remain on the market.
Legal DevelopmentsBoynton Beach Zantac Lawsuit Filed by Local Woman
James Parker · January 15, 2020
A Florida woman has filed a lawsuit alleging that Zantac manufacturers deliberately allowed an unsafe product to remain on the market.
Legal DevelopmentsBoynton Beach Zantac Lawsuit Filed by Local Woman
James Parker · January 15, 2020
A Florida woman has filed a lawsuit alleging that Zantac manufacturers deliberately allowed an unsafe product to remain on the market.
Legal DevelopmentsJohnson & Johnson Settlement Abruptly Concludes California Talc Trial
James Parker · January 7, 2020
Johnson & Johnson and plaintiffs Linda and Mark O’Hagan reached a midtrial settlement without jury verdict, meaning the jury will not be given an opportunity to make a decision that considers the FDA's finding of asbestos in talcum powder.
Legal DevelopmentsJohnson & Johnson Settlement Abruptly Concludes California Talc Trial
James Parker · January 7, 2020
Johnson & Johnson and plaintiffs Linda and Mark O’Hagan reached a midtrial settlement without jury verdict, meaning the jury will not be given an opportunity to make a decision that considers the FDA's finding of asbestos in talcum powder.
Legal DevelopmentsJohnson & Johnson Settlement Abruptly Concludes California Talc Trial
James Parker · January 7, 2020
Johnson & Johnson and plaintiffs Linda and Mark O’Hagan reached a midtrial settlement without jury verdict, meaning the jury will not be given an opportunity to make a decision that considers the FDA's finding of asbestos in talcum powder.
Legal DevelopmentsJohnson & Johnson Settlement Abruptly Concludes California Talc Trial
James Parker · January 7, 2020
Johnson & Johnson and plaintiffs Linda and Mark O’Hagan reached a midtrial settlement without jury verdict, meaning the jury will not be given an opportunity to make a decision that considers the FDA's finding of asbestos in talcum powder.
Legal DevelopmentsJohnson & Johnson Settlement Abruptly Concludes California Talc Trial
James Parker · January 7, 2020
Johnson & Johnson and plaintiffs Linda and Mark O’Hagan reached a midtrial settlement without jury verdict, meaning the jury will not be given an opportunity to make a decision that considers the FDA's finding of asbestos in talcum powder.
Legal DevelopmentsJohnson & Johnson Settlement Abruptly Concludes California Talc Trial
James Parker · January 7, 2020
Johnson & Johnson and plaintiffs Linda and Mark O’Hagan reached a midtrial settlement without jury verdict, meaning the jury will not be given an opportunity to make a decision that considers the FDA's finding of asbestos in talcum powder.
Legal DevelopmentsJohnson & Johnson Settlement Abruptly Concludes California Talc Trial
James Parker · January 7, 2020
Johnson & Johnson and plaintiffs Linda and Mark O’Hagan reached a midtrial settlement without jury verdict, meaning the jury will not be given an opportunity to make a decision that considers the FDA's finding of asbestos in talcum powder.
Legal DevelopmentsJohnson & Johnson Settlement Abruptly Concludes California Talc Trial
James Parker · January 7, 2020
Johnson & Johnson and plaintiffs Linda and Mark O’Hagan reached a midtrial settlement without jury verdict, meaning the jury will not be given an opportunity to make a decision that considers the FDA's finding of asbestos in talcum powder.
Legal DevelopmentsLos Angeles Jury Rules in Favor of Johnson & Johnson in Talc Mesothelioma Lawuit
James Parker · December 17, 2019
A jury in Los Angeles found Johnson & Johnson is not liable for causing Pui "Amy" Fong's mesothelioma, deciding its Baby Powder product was not defective nor a substantial threat.
Legal DevelopmentsLos Angeles Jury Rules in Favor of Johnson & Johnson in Talc Mesothelioma Lawuit
James Parker · December 17, 2019
A jury in Los Angeles found Johnson & Johnson is not liable for causing Pui "Amy" Fong's mesothelioma, deciding its Baby Powder product was not defective nor a substantial threat.
Legal DevelopmentsMonsanto Loses $10 Million in Maui Pesticide Case
Emma Schkloven · December 17, 2019
Monsanto pleaded guilty to spraying illegal pesticides in Maui, Hawaii, and has agreed to pay $10 million in charges.
Legal DevelopmentsLos Angeles Jury Rules in Favor of Johnson & Johnson in Talc Mesothelioma Lawuit
James Parker · December 17, 2019
A jury in Los Angeles found Johnson & Johnson is not liable for causing Pui "Amy" Fong's mesothelioma, deciding its Baby Powder product was not defective nor a substantial threat.
Legal DevelopmentsMonsanto Loses $10 Million in Maui Pesticide Case
Emma Schkloven · December 17, 2019
Monsanto pleaded guilty to spraying illegal pesticides in Maui, Hawaii, and has agreed to pay $10 million in charges.
Legal DevelopmentsMonsanto Loses $10 Million in Maui Pesticide Case
Emma Schkloven · December 17, 2019
Monsanto pleaded guilty to spraying illegal pesticides in Maui, Hawaii, and has agreed to pay $10 million in charges.
Legal DevelopmentsMonsanto Loses $10 Million in Maui Pesticide Case
Emma Schkloven · December 17, 2019
Monsanto pleaded guilty to spraying illegal pesticides in Maui, Hawaii, and has agreed to pay $10 million in charges.
Legal DevelopmentsMonsanto Loses $10 Million in Maui Pesticide Case
Emma Schkloven · December 17, 2019
Monsanto pleaded guilty to spraying illegal pesticides in Maui, Hawaii, and has agreed to pay $10 million in charges.
Legal DevelopmentsMonsanto Loses $10 Million in Maui Pesticide Case
Emma Schkloven · December 17, 2019
Monsanto pleaded guilty to spraying illegal pesticides in Maui, Hawaii, and has agreed to pay $10 million in charges.
Legal DevelopmentsLos Angeles Jury Rules in Favor of Johnson & Johnson in Talc Mesothelioma Lawuit
James Parker · December 17, 2019
A jury in Los Angeles found Johnson & Johnson is not liable for causing Pui "Amy" Fong's mesothelioma, deciding its Baby Powder product was not defective nor a substantial threat.
Legal DevelopmentsMonsanto Loses $10 Million in Maui Pesticide Case
Emma Schkloven · December 17, 2019
Monsanto pleaded guilty to spraying illegal pesticides in Maui, Hawaii, and has agreed to pay $10 million in charges.
Legal DevelopmentsLos Angeles Jury Rules in Favor of Johnson & Johnson in Talc Mesothelioma Lawuit
James Parker · December 17, 2019
A jury in Los Angeles found Johnson & Johnson is not liable for causing Pui "Amy" Fong's mesothelioma, deciding its Baby Powder product was not defective nor a substantial threat.
Legal DevelopmentsLos Angeles Jury Rules in Favor of Johnson & Johnson in Talc Mesothelioma Lawuit
James Parker · December 17, 2019
A jury in Los Angeles found Johnson & Johnson is not liable for causing Pui "Amy" Fong's mesothelioma, deciding its Baby Powder product was not defective nor a substantial threat.
Legal DevelopmentsLos Angeles Jury Rules in Favor of Johnson & Johnson in Talc Mesothelioma Lawuit
James Parker · December 17, 2019
A jury in Los Angeles found Johnson & Johnson is not liable for causing Pui "Amy" Fong's mesothelioma, deciding its Baby Powder product was not defective nor a substantial threat.
Legal DevelopmentsMonsanto Loses $10 Million in Maui Pesticide Case
Emma Schkloven · December 17, 2019
Monsanto pleaded guilty to spraying illegal pesticides in Maui, Hawaii, and has agreed to pay $10 million in charges.
Legal DevelopmentsLos Angeles Jury Rules in Favor of Johnson & Johnson in Talc Mesothelioma Lawuit
James Parker · December 17, 2019
A jury in Los Angeles found Johnson & Johnson is not liable for causing Pui "Amy" Fong's mesothelioma, deciding its Baby Powder product was not defective nor a substantial threat.
Legal DevelopmentsWomen Sue Allergan for Concealing Breast Implant Cancer Risk
Nicole Knight · December 6, 2019
Six women have filed a complaint alleging the manufacturer Allergan intentionally hid possible breast implant safety risks.
Legal DevelopmentsWomen Sue Allergan for Concealing Breast Implant Cancer Risk
Nicole Knight · December 6, 2019
Six women have filed a complaint alleging the manufacturer Allergan intentionally hid possible breast implant safety risks.
Legal DevelopmentsWomen Sue Allergan for Concealing Breast Implant Cancer Risk
Nicole Knight · December 6, 2019
Six women have filed a complaint alleging the manufacturer Allergan intentionally hid possible breast implant safety risks.
Legal DevelopmentsWomen Sue Allergan for Concealing Breast Implant Cancer Risk
Nicole Knight · December 6, 2019
Six women have filed a complaint alleging the manufacturer Allergan intentionally hid possible breast implant safety risks.
Legal DevelopmentsWomen Sue Allergan for Concealing Breast Implant Cancer Risk
Nicole Knight · December 6, 2019
Six women have filed a complaint alleging the manufacturer Allergan intentionally hid possible breast implant safety risks.
Legal DevelopmentsWomen Sue Allergan for Concealing Breast Implant Cancer Risk
Nicole Knight · December 6, 2019
Six women have filed a complaint alleging the manufacturer Allergan intentionally hid possible breast implant safety risks.
Legal DevelopmentsWomen Sue Allergan for Concealing Breast Implant Cancer Risk
Nicole Knight · December 6, 2019
Six women have filed a complaint alleging the manufacturer Allergan intentionally hid possible breast implant safety risks.
Legal DevelopmentsWomen Sue Allergan for Concealing Breast Implant Cancer Risk
Nicole Knight · December 6, 2019
Six women have filed a complaint alleging the manufacturer Allergan intentionally hid possible breast implant safety risks.
Legal DevelopmentsCalifornia Wildfires Spark Legal and Political Battles for PG&E
Nicole Knight · December 5, 2019
PG&E, the power provider implicated in the recent California wildfires, now faces legal action by the state.
Legal DevelopmentsCalifornia Wildfires Spark Legal and Political Battles for PG&E
Nicole Knight · December 5, 2019
PG&E, the power provider implicated in the recent California wildfires, now faces legal action by the state.
Legal DevelopmentsCalifornia Wildfires Spark Legal and Political Battles for PG&E
Nicole Knight · December 5, 2019
PG&E, the power provider implicated in the recent California wildfires, now faces legal action by the state.
Legal DevelopmentsCalifornia Wildfires Spark Legal and Political Battles for PG&E
Nicole Knight · December 5, 2019
PG&E, the power provider implicated in the recent California wildfires, now faces legal action by the state.
Legal DevelopmentsCalifornia Wildfires Spark Legal and Political Battles for PG&E
Nicole Knight · December 5, 2019
PG&E, the power provider implicated in the recent California wildfires, now faces legal action by the state.
Legal DevelopmentsCalifornia Wildfires Spark Legal and Political Battles for PG&E
Nicole Knight · December 5, 2019
PG&E, the power provider implicated in the recent California wildfires, now faces legal action by the state.
Legal DevelopmentsCalifornia Wildfires Spark Legal and Political Battles for PG&E
Nicole Knight · December 5, 2019
PG&E, the power provider implicated in the recent California wildfires, now faces legal action by the state.
Legal DevelopmentsCalifornia Wildfires Spark Legal and Political Battles for PG&E
Nicole Knight · December 5, 2019
PG&E, the power provider implicated in the recent California wildfires, now faces legal action by the state.
Legal DevelopmentsIn 3 Months, 20,000 More Plaintiffs Claim Roundup Caused Cancer
Emma Schkloven · November 26, 2019
The number of plaintiffs claiming Roundup caused their cancer has more than doubled to 42,700 in the last three months.
Legal DevelopmentsIn 3 Months, 20,000 More Plaintiffs Claim Roundup Caused Cancer
Emma Schkloven · November 26, 2019
The number of plaintiffs claiming Roundup caused their cancer has more than doubled to 42,700 in the last three months.
Legal DevelopmentsIn 3 Months, 20,000 More Plaintiffs Claim Roundup Caused Cancer
Emma Schkloven · November 26, 2019
The number of plaintiffs claiming Roundup caused their cancer has more than doubled to 42,700 in the last three months.
Legal DevelopmentsIn 3 Months, 20,000 More Plaintiffs Claim Roundup Caused Cancer
Emma Schkloven · November 26, 2019
The number of plaintiffs claiming Roundup caused their cancer has more than doubled to 42,700 in the last three months.
Legal DevelopmentsIn 3 Months, 20,000 More Plaintiffs Claim Roundup Caused Cancer
Emma Schkloven · November 26, 2019
The number of plaintiffs claiming Roundup caused their cancer has more than doubled to 42,700 in the last three months.
Legal DevelopmentsIn 3 Months, 20,000 More Plaintiffs Claim Roundup Caused Cancer
Emma Schkloven · November 26, 2019
The number of plaintiffs claiming Roundup caused their cancer has more than doubled to 42,700 in the last three months.
Legal DevelopmentsIn 3 Months, 20,000 More Plaintiffs Claim Roundup Caused Cancer
Emma Schkloven · November 26, 2019
The number of plaintiffs claiming Roundup caused their cancer has more than doubled to 42,700 in the last three months.
Legal DevelopmentsIn 3 Months, 20,000 More Plaintiffs Claim Roundup Caused Cancer
Emma Schkloven · November 26, 2019
The number of plaintiffs claiming Roundup caused their cancer has more than doubled to 42,700 in the last three months.
Legal DevelopmentsMaui Families File Suit Against Monsanto for Chemical Exposure
Emma Schkloven · November 19, 2019
Two families in Maui, Hawaii, have filed a lawsuit against Monsanto, claiming the company’s use of pesticides and chemicals led to birth defects in their newborns.Â
Legal DevelopmentsMaui Families File Suit Against Monsanto for Chemical Exposure
Emma Schkloven · November 19, 2019
Two families in Maui, Hawaii, have filed a lawsuit against Monsanto, claiming the company’s use of pesticides and chemicals led to birth defects in their newborns.Â
Legal DevelopmentsMaui Families File Suit Against Monsanto for Chemical Exposure
Emma Schkloven · November 19, 2019
Two families in Maui, Hawaii, have filed a lawsuit against Monsanto, claiming the company’s use of pesticides and chemicals led to birth defects in their newborns.Â
Legal DevelopmentsMaui Families File Suit Against Monsanto for Chemical Exposure
Emma Schkloven · November 19, 2019
Two families in Maui, Hawaii, have filed a lawsuit against Monsanto, claiming the company’s use of pesticides and chemicals led to birth defects in their newborns.Â
Legal DevelopmentsMaui Families File Suit Against Monsanto for Chemical Exposure
Emma Schkloven · November 19, 2019
Two families in Maui, Hawaii, have filed a lawsuit against Monsanto, claiming the company’s use of pesticides and chemicals led to birth defects in their newborns.Â
Legal DevelopmentsMaui Families File Suit Against Monsanto for Chemical Exposure
Emma Schkloven · November 19, 2019
Two families in Maui, Hawaii, have filed a lawsuit against Monsanto, claiming the company’s use of pesticides and chemicals led to birth defects in their newborns.Â
Legal DevelopmentsMaui Families File Suit Against Monsanto for Chemical Exposure
Emma Schkloven · November 19, 2019
Two families in Maui, Hawaii, have filed a lawsuit against Monsanto, claiming the company’s use of pesticides and chemicals led to birth defects in their newborns.Â
Legal DevelopmentsMaui Families File Suit Against Monsanto for Chemical Exposure
Emma Schkloven · November 19, 2019
Two families in Maui, Hawaii, have filed a lawsuit against Monsanto, claiming the company’s use of pesticides and chemicals led to birth defects in their newborns.Â
Legal DevelopmentsDoctor and Accomplice Charged in Transvaginal Mesh Surgery Scheme
Nicole Knight · November 14, 2019
A doctor and his consultant face multiple charges after tricking transvaginal mesh patients into getting unnecessary surgery.
Legal DevelopmentsDoctor and Accomplice Charged in Transvaginal Mesh Surgery Scheme
Nicole Knight · November 14, 2019
A doctor and his consultant face multiple charges after tricking transvaginal mesh patients into getting unnecessary surgery.
Legal DevelopmentsDoctor and Accomplice Charged in Transvaginal Mesh Surgery Scheme
Nicole Knight · November 14, 2019
A doctor and his consultant face multiple charges after tricking transvaginal mesh patients into getting unnecessary surgery.
Legal DevelopmentsDoctor and Accomplice Charged in Transvaginal Mesh Surgery Scheme
Nicole Knight · November 14, 2019
A doctor and his consultant face multiple charges after tricking transvaginal mesh patients into getting unnecessary surgery.
Legal DevelopmentsDoctor and Accomplice Charged in Transvaginal Mesh Surgery Scheme
Nicole Knight · November 14, 2019
A doctor and his consultant face multiple charges after tricking transvaginal mesh patients into getting unnecessary surgery.
Legal DevelopmentsDoctor and Accomplice Charged in Transvaginal Mesh Surgery Scheme
Nicole Knight · November 14, 2019
A doctor and his consultant face multiple charges after tricking transvaginal mesh patients into getting unnecessary surgery.
Legal DevelopmentsDoctor and Accomplice Charged in Transvaginal Mesh Surgery Scheme
Nicole Knight · November 14, 2019
A doctor and his consultant face multiple charges after tricking transvaginal mesh patients into getting unnecessary surgery.
Legal DevelopmentsDoctor and Accomplice Charged in Transvaginal Mesh Surgery Scheme
Nicole Knight · November 14, 2019
A doctor and his consultant face multiple charges after tricking transvaginal mesh patients into getting unnecessary surgery.
Legal DevelopmentsBirth Defects in Zofran Litigation Disputed, Despite Evidence Removed
James Parker · November 13, 2019
Recent litigation on Zofran has called into question expert testimony, which was removed from the evidence indicating that Zofran causes birth defects when used by pregnant women. Drug manufacturer, GlaxoSmithKline denies that causation of complications beyond heart defects and cleft palate can be proved. Though five cases were removed from the compilation of suits against GSK, the court proceedings wage on -- calling into question whether or not GSK should be required to update their product labeling with an adequate warning.
Legal DevelopmentsBirth Defects in Zofran Litigation Disputed, Despite Evidence Removed
James Parker · November 13, 2019
Recent litigation on Zofran has called into question expert testimony, which was removed from the evidence indicating that Zofran causes birth defects when used by pregnant women. Drug manufacturer, GlaxoSmithKline denies that causation of complications beyond heart defects and cleft palate can be proved. Though five cases were removed from the compilation of suits against GSK, the court proceedings wage on -- calling into question whether or not GSK should be required to update their product labeling with an adequate warning.
Legal DevelopmentsBirth Defects in Zofran Litigation Disputed, Despite Evidence Removed
James Parker · November 13, 2019
Recent litigation on Zofran has called into question expert testimony, which was removed from the evidence indicating that Zofran causes birth defects when used by pregnant women. Drug manufacturer, GlaxoSmithKline denies that causation of complications beyond heart defects and cleft palate can be proved. Though five cases were removed from the compilation of suits against GSK, the court proceedings wage on -- calling into question whether or not GSK should be required to update their product labeling with an adequate warning.
Legal DevelopmentsBirth Defects in Zofran Litigation Disputed, Despite Evidence Removed
James Parker · November 13, 2019
Recent litigation on Zofran has called into question expert testimony, which was removed from the evidence indicating that Zofran causes birth defects when used by pregnant women. Drug manufacturer, GlaxoSmithKline denies that causation of complications beyond heart defects and cleft palate can be proved. Though five cases were removed from the compilation of suits against GSK, the court proceedings wage on -- calling into question whether or not GSK should be required to update their product labeling with an adequate warning.
Legal DevelopmentsBirth Defects in Zofran Litigation Disputed, Despite Evidence Removed
James Parker · November 13, 2019
Recent litigation on Zofran has called into question expert testimony, which was removed from the evidence indicating that Zofran causes birth defects when used by pregnant women. Drug manufacturer, GlaxoSmithKline denies that causation of complications beyond heart defects and cleft palate can be proved. Though five cases were removed from the compilation of suits against GSK, the court proceedings wage on -- calling into question whether or not GSK should be required to update their product labeling with an adequate warning.
Legal DevelopmentsBirth Defects in Zofran Litigation Disputed, Despite Evidence Removed
James Parker · November 13, 2019
Recent litigation on Zofran has called into question expert testimony, which was removed from the evidence indicating that Zofran causes birth defects when used by pregnant women. Drug manufacturer, GlaxoSmithKline denies that causation of complications beyond heart defects and cleft palate can be proved. Though five cases were removed from the compilation of suits against GSK, the court proceedings wage on -- calling into question whether or not GSK should be required to update their product labeling with an adequate warning.
Legal DevelopmentsBirth Defects in Zofran Litigation Disputed, Despite Evidence Removed
James Parker · November 13, 2019
Recent litigation on Zofran has called into question expert testimony, which was removed from the evidence indicating that Zofran causes birth defects when used by pregnant women. Drug manufacturer, GlaxoSmithKline denies that causation of complications beyond heart defects and cleft palate can be proved. Though five cases were removed from the compilation of suits against GSK, the court proceedings wage on -- calling into question whether or not GSK should be required to update their product labeling with an adequate warning.
Legal DevelopmentsBirth Defects in Zofran Litigation Disputed, Despite Evidence Removed
James Parker · November 13, 2019
Recent litigation on Zofran has called into question expert testimony, which was removed from the evidence indicating that Zofran causes birth defects when used by pregnant women. Drug manufacturer, GlaxoSmithKline denies that causation of complications beyond heart defects and cleft palate can be proved. Though five cases were removed from the compilation of suits against GSK, the court proceedings wage on -- calling into question whether or not GSK should be required to update their product labeling with an adequate warning.
Legal DevelopmentsRiegel v. Medtronic: How the Landmark Case Limits Patient Rights
Carah Wertheimer · October 17, 2019
In 2008, a complex case set a legal precedent that dictates how Class III medical devices are approached. It's the landmark Supreme Court ruling, known as Riegel v. Medtronic, that changed everything. Now, those harmed by Class III medical devices struggle to seek legal recourse.
Legal DevelopmentsRiegel v. Medtronic: How the Landmark Case Limits Patient Rights
Carah Wertheimer · October 17, 2019
In 2008, a complex case set a legal precedent that dictates how Class III medical devices are approached. It's the landmark Supreme Court ruling, known as Riegel v. Medtronic, that changed everything. Now, those harmed by Class III medical devices struggle to seek legal recourse.
Legal DevelopmentsRiegel v. Medtronic: How the Landmark Case Limits Patient Rights
Carah Wertheimer · October 17, 2019
In 2008, a complex case set a legal precedent that dictates how Class III medical devices are approached. It's the landmark Supreme Court ruling, known as Riegel v. Medtronic, that changed everything. Now, those harmed by Class III medical devices struggle to seek legal recourse.
Legal DevelopmentsRiegel v. Medtronic: How the Landmark Case Limits Patient Rights
Carah Wertheimer · October 17, 2019
In 2008, a complex case set a legal precedent that dictates how Class III medical devices are approached. It's the landmark Supreme Court ruling, known as Riegel v. Medtronic, that changed everything. Now, those harmed by Class III medical devices struggle to seek legal recourse.
Legal DevelopmentsRiegel v. Medtronic: How the Landmark Case Limits Patient Rights
Carah Wertheimer · October 17, 2019
In 2008, a complex case set a legal precedent that dictates how Class III medical devices are approached. It's the landmark Supreme Court ruling, known as Riegel v. Medtronic, that changed everything. Now, those harmed by Class III medical devices struggle to seek legal recourse.
Legal DevelopmentsRiegel v. Medtronic: How the Landmark Case Limits Patient Rights
Carah Wertheimer · October 17, 2019
In 2008, a complex case set a legal precedent that dictates how Class III medical devices are approached. It's the landmark Supreme Court ruling, known as Riegel v. Medtronic, that changed everything. Now, those harmed by Class III medical devices struggle to seek legal recourse.
Legal DevelopmentsRiegel v. Medtronic: How the Landmark Case Limits Patient Rights
Carah Wertheimer · October 17, 2019
In 2008, a complex case set a legal precedent that dictates how Class III medical devices are approached. It's the landmark Supreme Court ruling, known as Riegel v. Medtronic, that changed everything. Now, those harmed by Class III medical devices struggle to seek legal recourse.
Legal DevelopmentsRiegel v. Medtronic: How the Landmark Case Limits Patient Rights
Carah Wertheimer · October 17, 2019
In 2008, a complex case set a legal precedent that dictates how Class III medical devices are approached. It's the landmark Supreme Court ruling, known as Riegel v. Medtronic, that changed everything. Now, those harmed by Class III medical devices struggle to seek legal recourse.
Legal DevelopmentsJohnson & Johnson Reached $20.4 Million Settlement With Ohio Counties in Landmark Opioid Case
Tess Francke · October 9, 2019
Johnson & Johnson reached a $20.4 million settlement with Cuyahoga and Summit counties in Ohio. The company resolves all claims by the counties without admission of liability.
Legal DevelopmentsJohnson & Johnson Reached $20.4 Million Settlement With Ohio Counties in Landmark Opioid Case
Tess Francke · October 9, 2019
Johnson & Johnson reached a $20.4 million settlement with Cuyahoga and Summit counties in Ohio. The company resolves all claims by the counties without admission of liability.
Legal DevelopmentsJohnson & Johnson Reached $20.4 Million Settlement With Ohio Counties in Landmark Opioid Case
Tess Francke · October 9, 2019
Johnson & Johnson reached a $20.4 million settlement with Cuyahoga and Summit counties in Ohio. The company resolves all claims by the counties without admission of liability.
Legal DevelopmentsJohnson & Johnson Reached $20.4 Million Settlement With Ohio Counties in Landmark Opioid Case
Tess Francke · October 9, 2019
Johnson & Johnson reached a $20.4 million settlement with Cuyahoga and Summit counties in Ohio. The company resolves all claims by the counties without admission of liability.
Legal DevelopmentsJohnson & Johnson Reached $20.4 Million Settlement With Ohio Counties in Landmark Opioid Case
Tess Francke · October 9, 2019
Johnson & Johnson reached a $20.4 million settlement with Cuyahoga and Summit counties in Ohio. The company resolves all claims by the counties without admission of liability.
Legal DevelopmentsJohnson & Johnson Reached $20.4 Million Settlement With Ohio Counties in Landmark Opioid Case
Tess Francke · October 9, 2019
Johnson & Johnson reached a $20.4 million settlement with Cuyahoga and Summit counties in Ohio. The company resolves all claims by the counties without admission of liability.
Legal DevelopmentsJohnson & Johnson Reached $20.4 Million Settlement With Ohio Counties in Landmark Opioid Case
Tess Francke · October 9, 2019
Johnson & Johnson reached a $20.4 million settlement with Cuyahoga and Summit counties in Ohio. The company resolves all claims by the counties without admission of liability.
Legal DevelopmentsJohnson & Johnson Reached $20.4 Million Settlement With Ohio Counties in Landmark Opioid Case
Tess Francke · October 9, 2019
Johnson & Johnson reached a $20.4 million settlement with Cuyahoga and Summit counties in Ohio. The company resolves all claims by the counties without admission of liability.
Legal DevelopmentsJudge Orders J&J to Pay $572 Million to Remediate Opioid Damages in Oklahoma
Tess Francke · September 5, 2019
After a nearly two-month trial, Judge Thad Balkman of Cleveland County District Court ruled Johnson & Johnson had intentionally played down the dangers and oversold the benefits of opioids. The company will pay $572 million for the community destruction caused by prescription painkillers.
Legal DevelopmentsJudge Orders J&J to Pay $572 Million to Remediate Opioid Damages in Oklahoma
Tess Francke · September 5, 2019
After a nearly two-month trial, Judge Thad Balkman of Cleveland County District Court ruled Johnson & Johnson had intentionally played down the dangers and oversold the benefits of opioids. The company will pay $572 million for the community destruction caused by prescription painkillers.
Legal DevelopmentsJudge Orders J&J to Pay $572 Million to Remediate Opioid Damages in Oklahoma
Tess Francke · September 5, 2019
After a nearly two-month trial, Judge Thad Balkman of Cleveland County District Court ruled Johnson & Johnson had intentionally played down the dangers and oversold the benefits of opioids. The company will pay $572 million for the community destruction caused by prescription painkillers.
Legal DevelopmentsJudge Orders J&J to Pay $572 Million to Remediate Opioid Damages in Oklahoma
Tess Francke · September 5, 2019
After a nearly two-month trial, Judge Thad Balkman of Cleveland County District Court ruled Johnson & Johnson had intentionally played down the dangers and oversold the benefits of opioids. The company will pay $572 million for the community destruction caused by prescription painkillers.
Legal DevelopmentsJudge Orders J&J to Pay $572 Million to Remediate Opioid Damages in Oklahoma
Tess Francke · September 5, 2019
After a nearly two-month trial, Judge Thad Balkman of Cleveland County District Court ruled Johnson & Johnson had intentionally played down the dangers and oversold the benefits of opioids. The company will pay $572 million for the community destruction caused by prescription painkillers.
Legal DevelopmentsJudge Orders J&J to Pay $572 Million to Remediate Opioid Damages in Oklahoma
Tess Francke · September 5, 2019
After a nearly two-month trial, Judge Thad Balkman of Cleveland County District Court ruled Johnson & Johnson had intentionally played down the dangers and oversold the benefits of opioids. The company will pay $572 million for the community destruction caused by prescription painkillers.
Legal DevelopmentsJudge Orders J&J to Pay $572 Million to Remediate Opioid Damages in Oklahoma
Tess Francke · September 5, 2019
After a nearly two-month trial, Judge Thad Balkman of Cleveland County District Court ruled Johnson & Johnson had intentionally played down the dangers and oversold the benefits of opioids. The company will pay $572 million for the community destruction caused by prescription painkillers.
Legal DevelopmentsJudge Orders J&J to Pay $572 Million to Remediate Opioid Damages in Oklahoma
Tess Francke · September 5, 2019
After a nearly two-month trial, Judge Thad Balkman of Cleveland County District Court ruled Johnson & Johnson had intentionally played down the dangers and oversold the benefits of opioids. The company will pay $572 million for the community destruction caused by prescription painkillers.
Legal DevelopmentsThe EPA Will Not Ban a Pesticide That Can Harm Kids’ Brains
Nicole Knight · August 28, 2019
The EPA has decided not to ban the pesticide chlorpyrifos despite evidence that the chemical harms children's brains. It is relevant to note that Dow Chemical, manufacturer of the chemical, donated significantly to the Trump administration's inaugural events.
Legal DevelopmentsThe EPA Will Not Ban a Pesticide That Can Harm Kids’ Brains
Nicole Knight · August 28, 2019
The EPA has decided not to ban the pesticide chlorpyrifos despite evidence that the chemical harms children's brains. It is relevant to note that Dow Chemical, manufacturer of the chemical, donated significantly to the Trump administration's inaugural events.
Legal DevelopmentsThe EPA Will Not Ban a Pesticide That Can Harm Kids’ Brains
Nicole Knight · August 28, 2019
The EPA has decided not to ban the pesticide chlorpyrifos despite evidence that the chemical harms children's brains. It is relevant to note that Dow Chemical, manufacturer of the chemical, donated significantly to the Trump administration's inaugural events.
Legal DevelopmentsThe EPA Will Not Ban a Pesticide That Can Harm Kids’ Brains
Nicole Knight · August 28, 2019
The EPA has decided not to ban the pesticide chlorpyrifos despite evidence that the chemical harms children's brains. It is relevant to note that Dow Chemical, manufacturer of the chemical, donated significantly to the Trump administration's inaugural events.
Legal DevelopmentsThe EPA Will Not Ban a Pesticide That Can Harm Kids’ Brains
Nicole Knight · August 28, 2019
The EPA has decided not to ban the pesticide chlorpyrifos despite evidence that the chemical harms children's brains. It is relevant to note that Dow Chemical, manufacturer of the chemical, donated significantly to the Trump administration's inaugural events.
Legal DevelopmentsThe EPA Will Not Ban a Pesticide That Can Harm Kids’ Brains
Nicole Knight · August 28, 2019
The EPA has decided not to ban the pesticide chlorpyrifos despite evidence that the chemical harms children's brains. It is relevant to note that Dow Chemical, manufacturer of the chemical, donated significantly to the Trump administration's inaugural events.
Legal DevelopmentsThe EPA Will Not Ban a Pesticide That Can Harm Kids’ Brains
Nicole Knight · August 28, 2019
The EPA has decided not to ban the pesticide chlorpyrifos despite evidence that the chemical harms children's brains. It is relevant to note that Dow Chemical, manufacturer of the chemical, donated significantly to the Trump administration's inaugural events.
Legal DevelopmentsThe EPA Will Not Ban a Pesticide That Can Harm Kids’ Brains
Nicole Knight · August 28, 2019
The EPA has decided not to ban the pesticide chlorpyrifos despite evidence that the chemical harms children's brains. It is relevant to note that Dow Chemical, manufacturer of the chemical, donated significantly to the Trump administration's inaugural events.
Legal DevelopmentsSeven Plaintiffs Refile J&J Talc Lawsuit to Prosecute Claire's and Others
James Parker · August 1, 2019
Judge George H. Wu of California granted case dismissal to seven plaintiffs in a talc lawsuit against Johnson & Johnson for their failure to label talc products. The plaintiffs will refile - adding more cases to their complaint and holding other companies liable.
Legal DevelopmentsSeven Plaintiffs Refile J&J Talc Lawsuit to Prosecute Claire's and Others
James Parker · August 1, 2019
Judge George H. Wu of California granted case dismissal to seven plaintiffs in a talc lawsuit against Johnson & Johnson for their failure to label talc products. The plaintiffs will refile - adding more cases to their complaint and holding other companies liable.
Legal DevelopmentsSeven Plaintiffs Refile J&J Talc Lawsuit to Prosecute Claire's and Others
James Parker · August 1, 2019
Judge George H. Wu of California granted case dismissal to seven plaintiffs in a talc lawsuit against Johnson & Johnson for their failure to label talc products. The plaintiffs will refile - adding more cases to their complaint and holding other companies liable.
Legal DevelopmentsSeven Plaintiffs Refile J&J Talc Lawsuit to Prosecute Claire's and Others
James Parker · August 1, 2019
Judge George H. Wu of California granted case dismissal to seven plaintiffs in a talc lawsuit against Johnson & Johnson for their failure to label talc products. The plaintiffs will refile - adding more cases to their complaint and holding other companies liable.
Legal DevelopmentsSeven Plaintiffs Refile J&J Talc Lawsuit to Prosecute Claire's and Others
James Parker · August 1, 2019
Judge George H. Wu of California granted case dismissal to seven plaintiffs in a talc lawsuit against Johnson & Johnson for their failure to label talc products. The plaintiffs will refile - adding more cases to their complaint and holding other companies liable.
Legal DevelopmentsSeven Plaintiffs Refile J&J Talc Lawsuit to Prosecute Claire's and Others
James Parker · August 1, 2019
Judge George H. Wu of California granted case dismissal to seven plaintiffs in a talc lawsuit against Johnson & Johnson for their failure to label talc products. The plaintiffs will refile - adding more cases to their complaint and holding other companies liable.
Legal DevelopmentsSeven Plaintiffs Refile J&J Talc Lawsuit to Prosecute Claire's and Others
James Parker · August 1, 2019
Judge George H. Wu of California granted case dismissal to seven plaintiffs in a talc lawsuit against Johnson & Johnson for their failure to label talc products. The plaintiffs will refile - adding more cases to their complaint and holding other companies liable.
Legal DevelopmentsSeven Plaintiffs Refile J&J Talc Lawsuit to Prosecute Claire's and Others
James Parker · August 1, 2019
Judge George H. Wu of California granted case dismissal to seven plaintiffs in a talc lawsuit against Johnson & Johnson for their failure to label talc products. The plaintiffs will refile - adding more cases to their complaint and holding other companies liable.
Legal DevelopmentsMarketing Tactics Mislead Consumers, Says Latest Testimony Against J&J Mesh
James Parker · July 31, 2019
In the latest transvaginal mesh trial, led by California Attorney General Xavier Becerra, expert testimony speaks to the way Johnson & Johnson's advertisements mislead consumers. Surgeon Margolis believes their mesh causes "substantial, significant, irreversible damage," despite consumer-friendly ads.
Legal DevelopmentsMarketing Tactics Mislead Consumers, Says Latest Testimony Against J&J Mesh
James Parker · July 31, 2019
In the latest transvaginal mesh trial, led by California Attorney General Xavier Becerra, expert testimony speaks to the way Johnson & Johnson's advertisements mislead consumers. Surgeon Margolis believes their mesh causes "substantial, significant, irreversible damage," despite consumer-friendly ads.
Legal DevelopmentsMarketing Tactics Mislead Consumers, Says Latest Testimony Against J&J Mesh
James Parker · July 31, 2019
In the latest transvaginal mesh trial, led by California Attorney General Xavier Becerra, expert testimony speaks to the way Johnson & Johnson's advertisements mislead consumers. Surgeon Margolis believes their mesh causes "substantial, significant, irreversible damage," despite consumer-friendly ads.
Legal DevelopmentsMarketing Tactics Mislead Consumers, Says Latest Testimony Against J&J Mesh
James Parker · July 31, 2019
In the latest transvaginal mesh trial, led by California Attorney General Xavier Becerra, expert testimony speaks to the way Johnson & Johnson's advertisements mislead consumers. Surgeon Margolis believes their mesh causes "substantial, significant, irreversible damage," despite consumer-friendly ads.
Legal DevelopmentsMarketing Tactics Mislead Consumers, Says Latest Testimony Against J&J Mesh
James Parker · July 31, 2019
In the latest transvaginal mesh trial, led by California Attorney General Xavier Becerra, expert testimony speaks to the way Johnson & Johnson's advertisements mislead consumers. Surgeon Margolis believes their mesh causes "substantial, significant, irreversible damage," despite consumer-friendly ads.
Legal DevelopmentsMarketing Tactics Mislead Consumers, Says Latest Testimony Against J&J Mesh
James Parker · July 31, 2019
In the latest transvaginal mesh trial, led by California Attorney General Xavier Becerra, expert testimony speaks to the way Johnson & Johnson's advertisements mislead consumers. Surgeon Margolis believes their mesh causes "substantial, significant, irreversible damage," despite consumer-friendly ads.
Legal DevelopmentsMarketing Tactics Mislead Consumers, Says Latest Testimony Against J&J Mesh
James Parker · July 31, 2019
In the latest transvaginal mesh trial, led by California Attorney General Xavier Becerra, expert testimony speaks to the way Johnson & Johnson's advertisements mislead consumers. Surgeon Margolis believes their mesh causes "substantial, significant, irreversible damage," despite consumer-friendly ads.
Legal DevelopmentsMarketing Tactics Mislead Consumers, Says Latest Testimony Against J&J Mesh
James Parker · July 31, 2019
In the latest transvaginal mesh trial, led by California Attorney General Xavier Becerra, expert testimony speaks to the way Johnson & Johnson's advertisements mislead consumers. Surgeon Margolis believes their mesh causes "substantial, significant, irreversible damage," despite consumer-friendly ads.
Legal Developments$2 Billion Verdict Reduced in Roundup Cancer Case
Lauren Styx · July 29, 2019
In May, a jury awarded the amount of $2 billion in punitive damages and $55 million in compensatory damages to a California couple who developed cancer after years of exposure to Roundup weedkiller. Last week, the California judge significantly reduced the award in this historic Roundup cancer case.
Legal Developments$2 Billion Verdict Reduced in Roundup Cancer Case
Lauren Styx · July 29, 2019
In May, a jury awarded the amount of $2 billion in punitive damages and $55 million in compensatory damages to a California couple who developed cancer after years of exposure to Roundup weedkiller. Last week, the California judge significantly reduced the award in this historic Roundup cancer case.
Legal Developments$2 Billion Verdict Reduced in Roundup Cancer Case
Lauren Styx · July 29, 2019
In May, a jury awarded the amount of $2 billion in punitive damages and $55 million in compensatory damages to a California couple who developed cancer after years of exposure to Roundup weedkiller. Last week, the California judge significantly reduced the award in this historic Roundup cancer case.
Legal Developments$2 Billion Verdict Reduced in Roundup Cancer Case
Lauren Styx · July 29, 2019
In May, a jury awarded the amount of $2 billion in punitive damages and $55 million in compensatory damages to a California couple who developed cancer after years of exposure to Roundup weedkiller. Last week, the California judge significantly reduced the award in this historic Roundup cancer case.
Legal Developments$2 Billion Verdict Reduced in Roundup Cancer Case
Lauren Styx · July 29, 2019
In May, a jury awarded the amount of $2 billion in punitive damages and $55 million in compensatory damages to a California couple who developed cancer after years of exposure to Roundup weedkiller. Last week, the California judge significantly reduced the award in this historic Roundup cancer case.
Legal Developments$2 Billion Verdict Reduced in Roundup Cancer Case
Lauren Styx · July 29, 2019
In May, a jury awarded the amount of $2 billion in punitive damages and $55 million in compensatory damages to a California couple who developed cancer after years of exposure to Roundup weedkiller. Last week, the California judge significantly reduced the award in this historic Roundup cancer case.
Legal Developments$2 Billion Verdict Reduced in Roundup Cancer Case
Lauren Styx · July 29, 2019
In May, a jury awarded the amount of $2 billion in punitive damages and $55 million in compensatory damages to a California couple who developed cancer after years of exposure to Roundup weedkiller. Last week, the California judge significantly reduced the award in this historic Roundup cancer case.
Legal Developments$2 Billion Verdict Reduced in Roundup Cancer Case
Lauren Styx · July 29, 2019
In May, a jury awarded the amount of $2 billion in punitive damages and $55 million in compensatory damages to a California couple who developed cancer after years of exposure to Roundup weedkiller. Last week, the California judge significantly reduced the award in this historic Roundup cancer case.
Legal DevelopmentsOklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids
James Parker · June 25, 2019
Oklahoma's latest opioid trial revealed that Johnson & Johnson pressured doctors to sell "more and more opioids." During proceedings, It also came to light that J&J heavily profited from its two subsidiaries Noramco and Tasmanian Alkaloids - major players in U.S. opioid epidemic.
Legal DevelopmentsOklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids
James Parker · June 25, 2019
Oklahoma's latest opioid trial revealed that Johnson & Johnson pressured doctors to sell "more and more opioids." During proceedings, It also came to light that J&J heavily profited from its two subsidiaries Noramco and Tasmanian Alkaloids - major players in U.S. opioid epidemic.
Legal DevelopmentsOklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids
James Parker · June 25, 2019
Oklahoma's latest opioid trial revealed that Johnson & Johnson pressured doctors to sell "more and more opioids." During proceedings, It also came to light that J&J heavily profited from its two subsidiaries Noramco and Tasmanian Alkaloids - major players in U.S. opioid epidemic.
Legal DevelopmentsOklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids
James Parker · June 25, 2019
Oklahoma's latest opioid trial revealed that Johnson & Johnson pressured doctors to sell "more and more opioids." During proceedings, It also came to light that J&J heavily profited from its two subsidiaries Noramco and Tasmanian Alkaloids - major players in U.S. opioid epidemic.
Legal DevelopmentsOklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids
James Parker · June 25, 2019
Oklahoma's latest opioid trial revealed that Johnson & Johnson pressured doctors to sell "more and more opioids." During proceedings, It also came to light that J&J heavily profited from its two subsidiaries Noramco and Tasmanian Alkaloids - major players in U.S. opioid epidemic.
Legal DevelopmentsOklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids
James Parker · June 25, 2019
Oklahoma's latest opioid trial revealed that Johnson & Johnson pressured doctors to sell "more and more opioids." During proceedings, It also came to light that J&J heavily profited from its two subsidiaries Noramco and Tasmanian Alkaloids - major players in U.S. opioid epidemic.
Legal DevelopmentsOklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids
James Parker · June 25, 2019
Oklahoma's latest opioid trial revealed that Johnson & Johnson pressured doctors to sell "more and more opioids." During proceedings, It also came to light that J&J heavily profited from its two subsidiaries Noramco and Tasmanian Alkaloids - major players in U.S. opioid epidemic.
Legal DevelopmentsOklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids
James Parker · June 25, 2019
Oklahoma's latest opioid trial revealed that Johnson & Johnson pressured doctors to sell "more and more opioids." During proceedings, It also came to light that J&J heavily profited from its two subsidiaries Noramco and Tasmanian Alkaloids - major players in U.S. opioid epidemic.
Legal DevelopmentsGuardians Act Would Require Doctors to File Adverse Event Reports
Nicole Knight · June 4, 2019
A new bill was introduced in the House of Representatives, inspired by Dr. Amy Reed whose cancer was spread by a medical device called a power morcellator. The Medical Device Guardians Act would require doctors to report unsafe devices to the U.S. Food and Drug Administration (FDA).
Legal DevelopmentsGuardians Act Would Require Doctors to File Adverse Event Reports
Nicole Knight · June 4, 2019
A new bill was introduced in the House of Representatives, inspired by Dr. Amy Reed whose cancer was spread by a medical device called a power morcellator. The Medical Device Guardians Act would require doctors to report unsafe devices to the U.S. Food and Drug Administration (FDA).
Legal DevelopmentsGuardians Act Would Require Doctors to File Adverse Event Reports
Nicole Knight · June 4, 2019
A new bill was introduced in the House of Representatives, inspired by Dr. Amy Reed whose cancer was spread by a medical device called a power morcellator. The Medical Device Guardians Act would require doctors to report unsafe devices to the U.S. Food and Drug Administration (FDA).
Legal DevelopmentsGuardians Act Would Require Doctors to File Adverse Event Reports
Nicole Knight · June 4, 2019
A new bill was introduced in the House of Representatives, inspired by Dr. Amy Reed whose cancer was spread by a medical device called a power morcellator. The Medical Device Guardians Act would require doctors to report unsafe devices to the U.S. Food and Drug Administration (FDA).
Legal DevelopmentsGuardians Act Would Require Doctors to File Adverse Event Reports
Nicole Knight · June 4, 2019
A new bill was introduced in the House of Representatives, inspired by Dr. Amy Reed whose cancer was spread by a medical device called a power morcellator. The Medical Device Guardians Act would require doctors to report unsafe devices to the U.S. Food and Drug Administration (FDA).
Legal DevelopmentsGuardians Act Would Require Doctors to File Adverse Event Reports
Nicole Knight · June 4, 2019
A new bill was introduced in the House of Representatives, inspired by Dr. Amy Reed whose cancer was spread by a medical device called a power morcellator. The Medical Device Guardians Act would require doctors to report unsafe devices to the U.S. Food and Drug Administration (FDA).
Legal DevelopmentsGuardians Act Would Require Doctors to File Adverse Event Reports
Nicole Knight · June 4, 2019
A new bill was introduced in the House of Representatives, inspired by Dr. Amy Reed whose cancer was spread by a medical device called a power morcellator. The Medical Device Guardians Act would require doctors to report unsafe devices to the U.S. Food and Drug Administration (FDA).
Legal DevelopmentsGuardians Act Would Require Doctors to File Adverse Event Reports
Nicole Knight · June 4, 2019
A new bill was introduced in the House of Representatives, inspired by Dr. Amy Reed whose cancer was spread by a medical device called a power morcellator. The Medical Device Guardians Act would require doctors to report unsafe devices to the U.S. Food and Drug Administration (FDA).
Legal Developments